Comparing morning and bedtime dosing of blood pressure medication
Official title: Morning Versus Bedtime Dosing of Antihypertensive Medication in Grade 1 Day-night Hypertension: a Multicenter Randomized Controlled Trial (Dosing-Time Trial)
Run by Shanghai Institute of Hypertension · NCT05089448 · Data updated 2026-11-12
This study is testing whether taking blood pressure medication in the morning or at bedtime works better to lower blood pressure in people with high blood pressure who haven't been treated before.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Shanghai Institute of Hypertension Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | January 28, 2021 |
| Main results expected | June 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | January 6, 2025 |
| Trial ID | NCT05089448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 with untreated hypertension or those who have stopped antihypertensive medications for at least two weeks.
✕Probably not a fit
Patients with secondary hypertension, obstructive sleep apnea, or other conditions affecting nighttime blood pressure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of morning versus bedtime dosing of antihypertensive medications on blood pressure levels in patients with hypertension. It will utilize both ambulatory and home blood pressure monitoring to assess nighttime, daytime, and 24-hour blood pressure reductions. The study will involve a multicenter randomized design, focusing on the potential differences in blood pressure control and target organ protection based on the timing of medication administration. The trial will include patients aged 18-70 who have not previously been treated for hypertension.
Why it matters
Potential benefit: If successful, this study could lead to improved blood pressure management strategies that enhance cardiovascular health.
How similar studies have gone: Previous studies have indicated the importance of nighttime blood pressure control, but this specific approach comparing dosing times in Chinese patients is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female patients aged 18-70 years old; 2. Never treated for hypertension or stopped using antihypertensive drugs for at least 2 weeks; 3. In the two screenings,the clinical systolic BP should be in the range of 140-159 mmHg, the diastolic BP \< 100 mmHg; 4. The average 24-hour systolic BP ≥130mmHg, daytime systolic BP ≥ 135 mmHg, and nighttime systolic BP ≥ 120 mmHg; 5. The average of bilateral brachial-ankle pulse wave velocity ≥14m/s; 6. Be willing to participate in the trial, sign the informed consent form, and be able to visit doctors by himself or herself. Exclusion Criteria: 1. Secondary hypertension; 2. Concomitant obstructive sleep apnea (STOP-BANG score ≥ 5), insomnia, Parkinson's syndrome, or nocturnal polyuria and other diseases that affect nighttime BP; 3. Need to work at night; 4. Ambulatory BP monitoring was invalid (\<70% valid readings, or \<20 daytime readings or \<7 nighttime readings); 5. Concomitant diseases that need taking medications influencing BP; 6. Coronary heart disease, myocardial infarction or stroke within recent 6 months; 7. Atrial fibrillation or frequent arrhythmia; 8. Abnormal liver function exemplified as an increased alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin (TBL) over the double of the upper limit of normal range; abnormal renal function exemplified as a serum creatinine ≥176 µmol/L; and plasma potassium ≥5.5 mmol/L or ≤3.5mmol/L; 9. Pregnant or lactating women; 10. Contraindications of angiotensin II receptor blocker or calcium channel blocker; 11. Other concomitant diseases which are considered not suitable to participate in the trial, such as thyroid diseases, acute infectious diseases, chronic mental diseases, tumor, etc.
Where it's running
-
Ruijin Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Li Yan, Professor
- Email: liyanshcn@163.com
- Phone: 021-64370045
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using ketone supplements to manage salt intake effects in older adults
This study is testing if ketone supplements can help older adults manage the harmful effects of a high-salt diet on their heart health and blood pressure.
-
Validating the CART BP ring cuffless blood pressure monitor
This study will test whether the CART BP ring gives blood pressure readings that match the standard cuff method in adults with suspected high or low blood pressure.
-
Focused ultrasound treatment for high blood pressure
This study is testing a new ultrasound treatment that aims to lower blood pressure by targeting fat around the kidneys in people with high blood pressure.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
TelTex4BP: A mobile program to help adults with hypertension in Nepal
A mobile text and phone-based program (TelTex4BP) helps adults with high blood pressure in Nepal take their medicines and adopt healthier habits to lower blood pressure.
-
Epidural spinal cord stimulation for managing blood pressure and low back pain
This study is testing if epidural spinal cord stimulation can help people with chronic low back pain and high blood pressure feel better by lowering their blood pressure and relieving their pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.